(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 6. Calmodulin dependent processes necessary for CBF excitation. Calmodulin
antagonists W-7 (50 µmol l-1) and calmidazolium (Calmid; 5
µmol l-1) both significantly reduced 10 mmol l-1
caffeine (Caff) excitation (W-7: N=5, P
0.003;
calmidazolium: N=4, P
0.006) and 100 µmol
l-1 dopamine (DA) excitation (W-7: N=5,
P
0.007; calmidazolium: N=5, P
0.001). W-7
also reduced 10 µmol l-1 TPep-NLS (TPep) excitation
(N=5, P
0.0001), however, calmidazolium did not
(N=3, P
0.17). *Significant reduction from
stimulated levels.